Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens

Journal of Clinical Microbiology

Volumn 49, Issue 10, 2011, Pages 3683-3686

  Garcia Sierra N ^a,b   Lacoma, A ^a,b   Prat, C ^a,b   Haba, L ^a   Maldonado, J ^c   Ruiz Manzano, J ^a,b   Gavin, P ^b,d,e   Samper, S ^b,d,e   Ausina, V ^a,b   Dominguez J ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Hospital Serveis Clinics   (Spain)

^d INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEC 460TB; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; GENE MUTATION; GENOTYPE MTBDRPLUS ASSAY; MOLECULAR DYNAMICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; RADIOMETRY; RPOB GENE; SENSITIVITY AND SPECIFICITY;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 80053482197     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01239-11     Document Type: Article

References (27)

1. Aristimuno, L., et al. 2006. Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela. BMC Microbiol. 6:90.
2. Arnold, C., et al. 2005. Single-nucleotide polymorphism-based differentiation and drug resistance detection in Mycobacterium tuberculosis from isolates or directly from sputum. Clin. Microbiol. Infect. 11:122-130. (Pubitemid 40253816)
3. Bao, J. R., R. N. Master, D. A. Schwab, and R. B. Clark. 2010. Identification of acid-fast bacilli using pyrosequencing analysis. Diagn. Microbiol. Infect. Dis. 67:234-238.
4. Boehme, C. C., et al. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015.
5. Bravo, L. T., et al. 2009. Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones. J. Clin. Microbiol. 47:3985-3990.
6. Brossier, F., N. Veziris, C. Truffot-Pernot, V. Jarlier, and W. Sougakoff. 2006. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J. Clin. Microbiol. 44:3659-3664. (Pubitemid 46768798)
7. Coll, P., et al. 2005. Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona. Microb. Drug Resist. 11:107-114. (Pubitemid 40705818)
8. Deretic, V., et al. 1995. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol. Microbiol. 17:889-900.
9. Diggle, M. A., and S. C. Clarke. 2004. Pyrosequencing: sequence typing at the speed of light. Mol. Biotechnol. 28:129-137.
10. Gali, N., et al. 2006. Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance. J. Clin. Microbiol. 44:201-205. (Pubitemid 43100601)
11. Garza-Gonzalez, E., et al. 2010. A pyrosequencing method for molecular monitoring of regions in the inhA, ahpC and rpoB genes of Mycobacterium tuberculosis. Clin. Microbiol. Infect. 16:607-612.
12. Halse, T. A., et al. 2010. Combined real-time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens. J. Clin. Microbiol. 48:1182-1188.
13. Heifets, L. 1988. Qualitative and quantitative drug-susceptibility tests in mycobacteriology. Am. Rev. Respir. Dis. 137:1217-1222.
14. Jureen, P., et al. 2006. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by pyrosequencing technology. J. Clin. Microbiol. 44: 1925-1929. (Pubitemid 43902137)
15. Kent, P. T., and G. P. Kubica. 1985. Public health micobacteriology: a guide for the level III laboratory. Centers for Disease Control, Atlanta, GA.
16. Lacoma, A., et al. 2008. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J. Clin. Microbiol. 46:3660-3667.
17. Marttila, H. J., J. Makinen, M. Marjamaki, and H. Soini. 2009. Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. Eur. J. Clin. Microbiol. Infect. Dis. 28:33-38.
18. Ramaswamy, S., and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29. (Pubitemid 29050434)
19. Ramaswamy, S. V., et al. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47:1241-1250. (Pubitemid 36372035)
20. Rattan, A., A. Kalia, and N. Ahmad. 1998. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg. Infect. Dis. 4:195-209. (Pubitemid 28311206)
21. Somoskovi, A., L. M. Parsons, and M. Salfinger. 2001. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res. 2:164-168. (Pubitemid 34187923)
22. Telenti, A., et al. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35:719-723. (Pubitemid 27083868)
23. Telenti, A., et al. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650. (Pubitemid 23083244)
24. Van Deun, A., et al. 2009. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J. Clin. Microbiol. 47:3501-3506.
25. Van Soolingen, D., et al. 2000. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J. Infect. Dis. 182:1788-1790.
26. World Health Organization. 2008. Anti-tuberculosis drug resistance in the world. Fourth global report (WHO/HTM/TB/2008.394). The WHO/ IUATLD global project on anti-tuberculosis drug resistance surveillance 2002-2007, World Health Organization, Geneva, Switzerland.
27. Zhao, J. R., et al. 2005. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 9:328-332.